Exchange: NASDAQ Sector: Healthcare Industry: Healthcare Plans
Current Signal: SELL (auto-tracking)
0.00% $2.48
America/New_York / 18 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 25.55 mill |
EPS: | -4.14 |
P/E: | -0.600 |
Earnings Date: | May 10, 2024 |
SharesOutstanding: | 10.30 mill |
Avg Daily Volume: | 0.574 mill |
RATING 2024-04-18 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Sell | |
DE: | Strong Sell | |
P/E: | Neutral | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.600 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -0.600 | industry: PE -5.65 |
DISCOUNTED CASH FLOW VALUE |
---|
$-1.763 (-171.08%) $-4.24 |
Date: 2024-04-18 |
Expected Trading Range (DAY) |
---|
$ 2.08 - 2.78 ( +/- 14.36%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-07 | Lamendola Damien | Buy | 910 000 | Class A Common Stock |
2024-01-11 | Powers John Paul | Buy | 150 000 | Class A Common Stock |
2024-01-11 | Powers John Paul | Buy | 0 | |
2024-01-16 | Lamendola Damien | Buy | 1 100 000 | Class A Common Stock |
2024-01-17 | Calabrese Jennifer Rosario | Buy | 50 000 | Class A Common Stock |
INSIDER POWER |
---|
97.29 |
Last 69 transactions |
Buy: 7 562 007 | Sell: 1 185 935 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $2.48 (0.00% ) |
Volume | 0.0310 mill |
Avg. Vol. | 0.574 mill |
% of Avg. Vol | 5.40 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:27 | sell | $1.121 | N/A | Active |
---|
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.